Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXL2T5
|
||||
Drug Name |
4-[3-(4-Cyano-benzyl)-2-methyl-3H-imidazol-4-ylmethyl]-piperazine-1-carboxylic acid 2-methoxymethyl-benzyl ester
|
||||
Synonyms |
CHEMBL64309
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H31N5O3
|
||||
Canonical SMILES |
COCc1ccccc1COC(=O)N2CCN(Cc3cnc(C)n3Cc4ccc(cc4)C#N)CC2
|
||||
InChI |
InChI=1S/C27H31N5O3/c1-21-29-16-26(32(21)17-23-9-7-22(15-28)8-10-23)18-30-11-13-31(14-12-30)27(33)35-20-25-6-4-3-5-24(25)19-34-2/h3-10,16H,11-14,17-20H2,1-2H3
|
||||
InChIKey |
FISVBHHSQNPBPG-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.